Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| At Risk Persons | 2 |
| Diseases | 2 |
| Foreign Countries | 2 |
| Health Behavior | 2 |
| Hypertension | 2 |
| Adults | 1 |
| Behavior Problems | 1 |
| Body Weight | 1 |
| Child Behavior | 1 |
| Children | 1 |
| Compliance (Psychology) | 1 |
| More ▼ | |
Author
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
| United Kingdom (Scotland) | 2 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkvon Stumm, Sophie; Deary, Ian J.; Kivimaki, Mika; Jokela, Markus; Clark, Heather; Batty, G. David – Journal of Child Psychology and Psychiatry, 2011
Background: Childhood behavior problems are associated with premature mortality. To identify plausible pathways that may account for this association, we explored the extent to which childhood behavior problems relate to health behaviors and health outcomes at midlife. Methods: The Aberdeen Children of the 1950s (ACONF) study comprises 12,500…
Descriptors: At Risk Persons, Gender Differences, Emotional Problems, Behavior Problems
Intelligence and Persisting with Medication for Two Years: Analysis in a Randomised Controlled Trial
Deary, Ian J.; Gale, Catharine R.; Stewart, Marlene C. W.; Fowkes, F. Gerald R.; Murray, Gordon D.; Batty, G. David; Price, Jacqueline F. – Intelligence, 2009
The study examined whether verbal intelligence is associated with persisting to take medication for up to two years. The design is a prospective follow-up of compliance with taking medication in high-risk individuals participating in a randomised, placebo-controlled trial set in Central Scotland. Participants were 1993 people aged between 50 and…
Descriptors: Outcomes of Treatment, Measures (Individuals), Intelligence Quotient, Foreign Countries
